david e. s md, fasam, faact specialty areas: addiction ... · specialty areas: addiction medicine....

DAVID E. SMITH, MD, FASAM, FAACT

Specialty Areas: Addiction Medicine Clinical Toxicology

License: Medical (California Board of Medical Quality Assurance)

Certification: Addiction Medicine (American Society of Addiction Medicine)

Addiction Medicine (American Board of Addiction Medicine) ______________________________________________________________________________

Birthplace: Bakersfield, California

Address: David E. Smith, M.D. and Associates

856 Stanyan Street San Francisco, CA 94117

Telephone: (415) 933-8759

Facsimile: (415) 933-8674

E-Mail: [email protected]

Short Biography for Introduction

• Diplomate, American Board of Addiction Medicine • Medical Director, Center Point, San Rafael, California • Chair, Newport Academy, Adolescent Addiction Treatment, Corona Del Mar, California • Adjunct Professor, University of California, San Francisco • Former Medical Director, California State Department of Alcohol and Drug Programs • Fellow and Past President, American Society of Addiction Medicine • Fellow, American Academy of Clinical Toxicologists • Founder, Haight Ashbury Free Medical Clinic, San Francisco, California

______________________________________________________________________________

David E. Smith, M.D.

I. Education 1. East Bakersfield High School 1956 2. Bakersfield College, A.A. 1958 3. University of California, Berkeley, B.A., Zoology 1960 4. University of California, San Francisco, M.S., Pharmacology 1964 5. University of California, San Francisco, M.D., Medicine 1964 6. San Francisco General Hospital, Internship 1965 7. University of California, San Francisco, Post-Doctoral Fellowship, Pharmacology and Toxicology 1965-1967 8. Institute for the Advanced Study of Human Sexuality, Ph.D. coursework 1979-1984 II. Current Medical Practice • Medical Director, Center Point, Inc., San Rafael, California 1993-Present • Medical Review Officer - PG&E, San Francisco, California 1990-Present • Chair, Newport Academy, Adolescent Addiction Treatment, Corona Del Mar, California 2008-Present • Adjunct Professor, University of California San Francisco 2000-Present • Diplomate, American Board of Addiction Medicine 2009-Present • Fellow, American Society of Addiction Medicine 1997-Present • Fellow, American Academy of Clinical Toxicology 1987-Present III. Past Medical Practice • Executive Medical Director, Prometa Center, San Francisco 2006-2008

• Medical Director, Haight Ashbury Free Clinics 1967-2006 • Chief of Addiction Medicine, Bayside Marin, Tiburon, California 2006-2008 • Research Director, MPI Treatment Services, Summit Medical Center, Oakland, California 1984-2003 • Medical Director, California Collaborative Center for Substance Abuse Policy Research, University of California, San Francisco 1998-2007 • Medical Director, California State Department of Alcohol and Drug Programs 1998-2006


• Doping Control Officer, Winter Olympics, Salt Lake City 2002 • Medical Staff, Fresno Community Hospital and Medical Center, Community Hospitals of Central California, Fresno, California 1993-1995 • Medical Review Officer - University of California, Berkeley 1996-2006 • Medical Director, Forest Farms Community, Adolescent Drug Treatment Program, Forest Knolls, California 1983-1994 • Consultant on Drug Abuse, Gladman Memorial Psychiatric Hospital, Oakland, California 1981-1986 • Consultant on Drug Abuse, Marin Alternative Community Therapy, San Rafael, California 1978-1984 • Member, U.S. Olympic Team, Doping Control Section 1984 • San Francisco Psychiatric Hospital Courtesy Staff 1973-1977 • Physician, Presbyterian Alcoholic Clinic 1965-1966 • Physician, Contra Costa Alcoholic Clinic 1965-1968 • Director, Alcohol & Drug Abuse Screening Unit, San Francisco General Hospital 1965-1972 IV. Teaching Activities 1. Adjunct Professor, University of California, San Francisco 2000-present 2. Visiting Research Professor, University of California, San Francisco 1998-2000 3. Associate Clinical Professor of Occupational Health and Clinical Toxicology, Department of Occupational Health, University of California, San Francisco 1986-Present 4. Associate Clinical Professor of Clinical Toxicology, University of California, San Francisco 1967-Present 5. Lecturer in Criminology, University of California, Berkeley 1968-1969 6. Co-Director, National Training Center for Drug Education, San Francisco, California 1970

7. Preceptor, Community Medicine Preceptorship Program, University of California, San Diego 1972-1973 8. Faculty Member, National College of Juvenile Justice, University of Nevada, Reno, Nevada 1971-1976 9. Honorary Lecturer, Department of Medicine, Addiction Research Foundation Clinical Institute, Toronto, California 1975-1990


10. Visiting Clinical Professor of Behavioral Pharmacology, University of Nevada Medical School 1975-Present 11. Lecturer on Substance Abuse, UC Berkeley-UC San Francisco Joint Medical School Program 1980-Present

12. Guest Lecturer on Substance Use Disorders Assessment & Management of Common Psychiatric Symptoms Course, UCSF Department of Community Health Systems November 1999

V. Consultancies

1. Consultant, Drug Abuse Division of Alcoholism, California Department of Public Health 1966-1968

2. Consultant, Drug Abuse, Veteran’s Administration Hospital 1968-Present 3. Consultant, Student Association for the Study of Hallucinogens 1968-1980 4. Consultant, National Commission on Venereal Disease 1971-1972 5. Consultant, President’s Special Action Office on Drug Abuse Prevention 1971-1973 6. Consultant, Committee on Dangerous Drugs, California Medical Association 1970-1973 7. Consultant on Drug Abuse, United States Air Force 1972-1973 8. Consultant on Drug Abuse, National Association of Drug Abuse 1972-1984

9. Consultant on Drug Abuse, SAODAP 1972-1973 10. Consultant on Drug Abuse, NIMH 1972-1973 11. Consultant to NIMH - National Clearinghouse on Drug Abuse Information 1972-1974 12. Consultant to NIMH - NARB Drug Treatment Program 1972-1974

13. Consultant to Committee on Alcoholism and Drug Dependence, 1973 House of Delegates 1973

14. Advisory Council, Department of Health, Education & Welfare 1973 15. Advisory Board to PHARMCHEM Research Foundation 1975-1984 16. Consultant, Stanford Research Institute on Drug Abuse 1975-1976 17. Consultant, Alcohol and Drug Abuse, AMA Council on Scientific Affairs 1977 18. Advisory Committee, San Francisco Health Department, Sexual Trauma Center 1977 19. Advisory Council on Narcotics and Drug Abuse, Sacramento, California 1979-1980

20. Advisory Committee on Controlled Substances, Food and Drug Administration, Washington, DC 1978-1983


21. Consultant, Menninger Clinic, Topeka, Kansas 1983-1995 22. Consultant, San Francisco General Hospital, Department of Psychiatry 1966-Present 23. Consultant, Committee on Alcoholism and Other Drug Dependencies, California Medical Association 1978-1990 24. Consultant, American Medical Association Diagnostic and Therapeutic Technology Assessment 1982-1985 25. Consultant and Member Advisory Board, Marin A.C.T. 1982-1985 26. Alternate Delegate to the American Medical Association representing the American Medical Society on Alcoholism and Other Drug Dependencies 1989-Present

27. American Psychiatric Association: Consultant to Substance Abuse Section, Work Group to revise DSM-III 1990

28. Johnson Institute: Faculty Training Position 1990

28. Alcohol, Tobacco & Other Drugs Advanced Practice Nursing Subspecialty Program: Advisory Committee 1998 30. United States Olympic Committee National Anti-Doping Program Review 1998

31. International Society of Addiction Medicine (ISAM) Chairman, Health Economics Committee 1999- Present

VI. Coordinating Agencies 1. Founder, Former President and Former Coordinating Committee Member, National Free Clinic Council 1968-1972 VII. Memberships 1. Member, U.S. Office of Education, Drug Education Project and Assistant Director, West Coast Regional Training Center 1970 2. Member, Advisory Board of Contemporary Drug Problems 1971 3. Member, Governor’s Task Force on Veteran Drug Addicts 1971

4. Member, San Francisco Association for Mental Health Professional Advisory Committee 1970-1973

5. Member, San Francisco Medical Society for Alcoholism and Dangerous Drugs Committee 1970-1985 6. Ad Hoc Committee - City College Student Health Services 1972 7. Member, Scientific Review Boards Methadone Maintenance Program 1972


8. Member, Pan American Medical Association 1972-1995 9. Member, Scientific Advisory Committee on Drugs, National Research Council 1971-1972 10. Member, PAMA Section on Drug Abuse and Narcotic Addiction 1972-1995 11. Member, PAMA Section on Forensic Medicine 1972-1995 12. Associate Member, World Medical Association 1972-1995 13. Member, National Association State Drug Coordinator, Drug Abuse Prevention Task Force 1982-1995 14. Board Member, Westside Community Mental Health Center 1973 15. Member, Royal Society of Medicine, London, England 1973

16. Member, Conference Organizing Committee First Annual National Drug Abuse Conference, Chicago, Illinois 1974

17. Board of Directors Community Management Center 1973 18. Member, Clinical Review Board, National Institute on Drug Abuse 1973-Present 19. Co-Chairman, National Free Clinic Council, National Free Clinic Physicians Caucus 1974 20. Member, Board of Directors, Haight Ashbury Switchboard 1974-1975 21. Member, American College of Emergency Physicians 1972-1995

21. Member, Advisory Board of the National Drug Abuse Center for Training and Resource Development 1975-1995

22. Member, Professional Advisory Board, “The Door: A Center of Alternatives,” New York, New York 1974-1985

24. Member, San Francisco Heart Association 1976-1977 25. Member, Northwestern Medical Association, Inc. 1974-1990 26. Member, Board of Advisors, Awareness House, Oakland, California 1977 27. Member, California PCP Training Project Technical Advisory Group 1978-1979 28. Member, Physicians for Prevention, White House Office on Drug Control Policy 1995-Present 29. Member, National Council on Alcoholism and Drug Dependence, Inc. 1995-Present 30. Member, Prescription Drug Research Center, Chicago, Illinois 2004


VII. Societies

1. Member, San Francisco Medical Society Drug Abuse Committee, Physician’s Well Being Committee 1965-Present

2. San Francisco Medical Society Local Health Affairs Committee 1997-Present 3. San Francisco Medical Society Editorial Board 1999-Present

4. Member, California Medical Association Drug Abuse Committee, Prescription Drug Committee 1965-Present 5. Member, American Medical Association Drug Abuse Committee 1965-Present 6. Member, California Society of Addiction Medicine 1972-Present

7. Member, American Society of Addiction Medicine Board of Directors, Special Status Committee, Nomenclature Committee 1972-Present

8. Member, Board of Medical Quality Assurance, Diversion Liaison Committee 1982-1984 9. Member, Phi Beta Kappa 1960-Present 10. Member, Sigma Xi 1960-Present 11. American Public Health Association (Mental Health Section) 1968-Present 12. Charter Member, American Academy of Clinical Toxicology 1968-Present

13. Charter Member and Chairman, Editorial Committee, California Society for the Treatment of Alcoholism and other Drug Dependencies 1973-Present

14. Member, San Francisco Society Board of Medical Quality Assurance Committee 1979 15. Member, Western Pharmacology Society 1970-Present 16. Member, Committee on the Well Being of Physicians, 1997-Present California Medical Association 17. Chairman, Well Being Committee, American Society of Addiction Medicine 1999 18. Founding Board of Directors, International Society of Addiction Medicine (ISAM) 1999 19. Chairman, Pain and Addiction Committee, International Society of Addiction 2002 Medicine IX. Training Activities 1. Chairperson, National Drug Abuse Conference, San Francisco 1977 2. National Institute on Drug Abuse Training Advisory Committee 1978-1990 3. Director, Amphetamine Evaluation and Physician Training Project 1977-1979


4. Director, PCP Research and Training Project 1978-1980 5. Co-Director, Impaired Health Professional Research and Training 1980-1990 6. Director, Benzodiazepine Research & Physician Training Project 1980-1985 7. Co-Director, Drug Abuse and Sexual Dysfunction Research and Physician Training Project 1979-1985 8. Medical Director, Haight Ashbury Training and Education Project 1980-1995 X. Political and Governmental Positions/Activities

1. Member, Task Force on Domestic Affairs at the Advisory Council of the Elected Officials to the Democratic National Committee: A Study Group in Drug Abuse and Alcoholism 1971 2. Co-Chairman, Northern California Physicians for McGovern for President 1972 3. Chairman, Northern California Physicians for Carter for President 1975-1976 4. Health Advisor to President Jimmy Carter 1976 5. Alcoholism and Drug Abuse Sub-Committee for the Democratic National Platform 1976 6. Member, Governor’s Advisory Panel on Narcotics and Drug Abuse 1977 7. Consultant, FDA Controlled Substances Advisory Committee 1978-1983 8. Consultant, National Institute of Drug Abuse 1976-1984

9. Member, Committee on Impaired Health Professionals, California Society for the Treatment of Alcoholism and Other Drug Dependencies 1980

10. Physician’s Representative on the California State Controlled Substance Prescription Drug Advisory 1993 XI. Honors 1. Borden Research Award 1964 2. Research Award 1966 3. California Junior College Alumnus of the Year 1969 4. Chancellor’s Award for Community Service, University of California, San Francisco 1974 5. 16th Annual San Francisco Examiner “Ten Most Distinguished” Award 1974 6. American Medical Association Physician’s Recognition Award in Continuing Education 1978


7. Martin Luther King Humanitarian Award, Glide Methodist Church, San Francisco, California 1980 8. Drug Abuse Treatment Award, California Association State Drug Abuse Coordinators 1983 9. Drug Abuse Treatment Award, National Association, State Alcohol and Drug Abuse

Coordinators 1984

10. Career Achievement Award, National Association of State Alcohol and Drug Abuse Directors (NASADAD) and National Prevention Network 1994

11. University of California Medal of Honor Recipient 1995 12. Community Works Award, State of California Drug Policy Office 1996 13. The Best Doctors in America: Pacific Region 1996-1997 14. California Medicine Magazine; named one of “California’s 100 Most Interesting and Influential Health Care Leaders” 1997 15. California Association of Alcoholism and Drug Abuse Counselors (CAADAC) Council of Fellows 1998 16. Haight Ashbury Free Clinics, Lifetime Achievement Award 1998 17. Geri Taylor Memorial Award, Northern California Psychiatric Society 1998 18. Talbott Recovery Campus Award 1999 19. Governor’s Older Worker and Exemplary Employer Recognition Award 2002 XII. Editorial Positions

1. Founder and Executive Editor, Journal of Psychoactive Drugs (formerly known as Journal of Psychedelic Drugs) 1967-Present

2. Member, Editorial Board, The Journal, the official publication of the Toronto Addiction Research Institute 1974-1993

3. Member, Editorial Board, Clinical Toxicology 1975-2007 4. Co-Editor, Addictions Alert Newsletter 1987-2005 5. Contemporary Drug Problems: A Law Quarterly 6. Journal of American College of Emergency Physicians 7. Editorial Board of Drug Abuse and Drug Education 8. Editorial Board of Clinical Toxicology 9. Editorial Advisory Board of the American Journal of Drug and Alcohol Abuse 1973 10. Advisory Board, The Center for the Study of Non-Medical Drug Use 1976-Present


11. Advisory Board, Women In Crisis, Inc., New York 1981-2005 12. Editorial Advisory Board, Journal of the American Medical Association 1984-2006 13. Medical Editor, AlcoholMD.com 2000-Present 14. Editorial Board, Journal of Addiction Medicine 2007-2002 XIII. Research Projects

1. Assistant Principal Investigator, C.R.C. Dug Abuse Social Rehabilitation and Demonstration Project. Department of Health, Education and Welfare Grant #15-P-55894. Research on vocational rehabilitation for drug abusers, including support for psychological services and vocational training through Haight Ashbury Free Clinics. National seminar with four-volume proceedings funded by President’s Special Action Office for Drug Abuse Prevention.

1972-1974 2. Assistant Principal Investigator, West Coast Polydrug Research and Treatment Project.

Investigated patterns of polydrug abuse and provided treatment and training for physicians. Funded by the President’s Special Action Office for Drug Abuse Prevention.

1973-1974 3. Associate Principal Investigator, San Francisco Polydrug Project. NIDA grant (number unavailable).

1974-1977 4. Principal Investigator and Director, Amphetamine Evaluation and Physician Training Project.

Research on treatment of amphetamine abuse and treatment, including several symposiums and national conference with bound proceedings. Funded by Smith Kline & French.

1977-1979 5. Principal Investigator and Director, PCP Research and Training Project. Research on treatment of

PCP abuse and training for physicians and law enforcement including national conference. Diverse government and private funding sources.

1978-1980 5. Co-Director, Drug Abuse and Sexual Dysfunction Research and Physician Training Project.

Presented national conference and proceedings. Various funding sources. 1979-1985 6. Co-Principal Investigator and Director, Benzodiazepine Research and Physician Training Project.

Developed international physician clinical research network on effects of benzodiazepines at clinical and non-clinical dosages. Resulted in international conference, numerous articles, books and proceedings. Currently used benzodiazepine withdrawal protocol is named the Smith & Wesson Protocol. Funded by Hoffmann LaRoche, Nutley, NJ.

1980-1985 7. Director, Impaired Health Professional Research and Training. Ongoing clinical research on the

treatment of addicted physicians and other health professionals leading to development of diversion and treatment programs for physicians, nurses, and other health professionals. Variable private funding.

1980-2006 8. Co-Principal Investigator, A controlled study of naltrexone maintenance. NIDA Research Grant #RO1 DA03516.

1985-1989 9. Principal Investigator, A controlled study of L-tryptophan in cocaine withdrawal. NIDA Research Grant # R01 DA04182.

1987-1991


10. Co-Principal Investigator, A double-blind multi center trial of gepirone and placebo in the treatment of cocaine dependence. Collaborative site study funded by Bristol-Myers Squibb. 1990-1991

11. Co-Principal Investigator, A controlled study of naltrexone induction with clonidine. NIDA Research Grant #R01 DA06038.

1990-1994 11. Co-Principal Investigator, An open usage study of Trexan as adjunctive treatment with psycho

social therapy for individuals with alcoholism. Collaborative site study funded by DuPont Merck. 1993-1995 12. Co-Principal Investigator, An observational study on the clinical management of patients treated

with naltrexone (ReVia TM ) for alcohol dependence. Collaborative site study funded by DuPont Merck.

1995-1996 13. Co-Principal Investigator, Reducing cocaine relapse with naltrexone, a placebo-controlled,

double-blind, randomized clinical trial to test the efficacy of naltrexone for reducing relapse among cocaine abusers who drink alcohol. NIDA Research Grant #R01 DA08871.

1995-1998 14. Consultant, Abuse of Rohypnol in Austin and South Texas, a field work and qualitative data

analysis of the phenomenon and scope of Rohypnol abuse in the southern and border areas of Texas. Funded by Hoffmann-LaRoche.

1996-1997 15. Principal Investigator, Fenfluramine/dexfenfluramine use pattern surveillance program.

Monitored for development of abuse of fenfluramine or dexfenfluramine. Funded by Wyeth Ayerst.

1996-1998 16. Consultant, Tyrosine for methamphetamine dependence, a placebo-controlled, double-blind,

randomized clinical trial to test the efficacy of tyrosine as an adjunct to psycho social treatment in abstinence initiation in methamphetamine abusers. NIDA Research Grant No. R01 DA10739.

1996-1999 17. Co-Principal Investigator, Acamprosate in-patients with alcohol dependence, a double-blind

controlled safety and efficacy study at two active dosage levels. Collaborative site study funded by Lipha Pharmaceuticals.

1997-1998 18. Consultant, Rohypnol abuse in Florida, a field work and qualitative data analysis of the

phenomenon and scope of Rohypnol abuse in Florida. Funded by Hoffmann-LaRoche. 1997-1998 19. Co-Principal Investigator, A long-term safety study of SCH 39166 in the treatment of cocaine

dependence. Collaborative site study funded by Schering-Plough Research Institute. 1998 20. Consultant, Emerging drugs of abuse in California, a field work and qualitative data analysis

project to investigate new drug abuse patterns in California. Funded by Hoffmann-LaRoche. 1998-1999 21. Principal Investigator and Medical Director, California State Department of Alcohol and Drug

Programs Contract No. 99-00205. Administered through Institute on Health and Aging, UCSF. 1998-2006

22. Co-Investigator, Modafinil use pattern surveillance program. Monitoring for possible development of abuse or misuse of Modafinil (Provigil TM). Funded by Cephalon, Inc.

1998-2001 23. Consultant, Methamphetamine dependence and the risk of HIV infection, a longitudinal study of

in-treatment and out-of-treatment methamphetamine users in San Francisco and Sacramento to examine HIV seroprevalence, seroincidence, risks behaviors, and their antecedents. NIDA Research Grant No. R01 DA10641.

1998-2002


24. Principal Investigator, Technical Assistance - Prevention Outcomes and Measures. California State Department of Alcohol and Drug Programs Contract No. 98-00253. Administered through Institute for Health and Aging, UCSF.

1999-2001 25. Principal Investigator, Adolescent Services, California Alcohol and Drug Programs Contract.

Administered through Institute for Health and Aging, UCSF. 2000-2003 26. Principal Investigator, County Profiles, California Alcohol and Drug Programs Contract.

Administered through Institute on Health and Aging, UCSF. 2000-2003 XIV. Bibliography 1. Smith DE & Katzung BG. Mechanical Properties of Hibernating Heart Muscle. American Heart Journal, April, 1966. 2. Smith DE. Lysergic Acid Diethylamide: An Historical Perspective. Journal of Psychedelic Drugs, Volume 1(1), p. 307,

1967. 3. Shubart P, Smith DE & Conrich R. The Concept of Regionalized Health Facility for the Haight-Ashbury Subculture.

Journal of Psychedelic Drugs, Volume 1(1), pp.53-55, 1967. 4. Smith DE. STP: A New Hallucinogen. Monograph - Adverse Reactions to Hallucinogenic Drugs, NIMH Publications,

1967. 5. Smith DE, Fisher CM & Hine CH. Effects of Chlorpromazine Phenobarbital and Iproniazid on the Polyphasic

Mortality Curve of Aggregate Amphetamine Toxicity, Applied Pharmacology, Volume 10, p. 402, March, 1967. 6. Smith DE. The Role of B Vitamins in Alcoholism Debated. Quarterly Alcohol Review, October, 1967. 7. Smith DE, Fort J & Craton D. Psychoactive Drugs. Journal of Psychedelic Drugs, Volume 1, pp. 150-158, July, 1967. 8. Smith DE & Shubart P. A Regionalized Medical Clinic in the Haight-Ashbury. California’s Health, Volume 25(5), pp.

3-6, 1968. 9. Smith DE & Rose AJ. LSD: Its Use, Abuse and Suggested Treatment (Observations by the Haight Ashbury Medical

Clinic). Journal of Psychedelic Drugs, Volume 1(2), pp. 117-123, 1968. 10. Meyer FH & Smith DE. AB1399: Report to the Legislature, California Drug Abuse Treatment and Research

Facilities. California Medicine, September, 1968. 11. Smith DE & Meyer FH. The New Generation and the New Drugs. California’s Health, Volume 25(8) pp. 7-11, 1968. 12. Smith DE. The Role of Nicotinic Acid Derivatives in the Treatment of Acute Toxic Psychosis. Journal of Psychedelic

Drugs, Volume 1(2), pp. 112-114, 1968. 13. Meyer FH, Rose AJ & Smith DE. Incidents Involving the Haight-Ashbury Population and Some Uncommonly Used

Drugs. Journal of Psychedelic Drugs, Volume 1(2), pp. 139-146, 1968. 14. Sankot M & Smith DE. Drug Problems in the Haight-Ashbury. American Journal of Nursing, August, 1968. 15. Smith DE. A View of the Hippie “Non-Student”. 1968 Annual Proceedings of the National College Association, April,

1968. 16. Smith DE. Speed Kills - Patterns of High Dose Methamphetamine Abuse. 1968 Annual Proceedings of the National

College Association, April, 1968.


17. Smith DE. Methamphetamine Abuse. Bulletin of the Los Angeles County Medical Society, pp. 22-24, June 6, 1968.

18. Smith DE. Youth and Drug Abuse. The Mind Benders, McGraw Publications, 1968. 19. Smith DE & Rose AJ. Observations in the Haight-Ashbury Medical Clinic of San Francisco - Health Problems in a

Hippie Subculture. Clinical Pediatrics, Volume 6, pp. 313-322, 1968.

20. Smith DE. Speed Kills. Santa Cruz Health Services Proceedings, Student Drug Conference, April, 1968.

21. Smith DE. Contemporary Patterns of Youth and Drug Abuse. Mind Drugs, McGraw Hill Publications, 1969. 22. Smith DE. LSD and the Psychedelic Syndrome. Annual Proceedings of the California Advisory Council on Education

Research, California Journal of Education Research, November, 1968. 23. Meyer FH & Smith DE. Drug Abuse Recommendations for California Treatment and Research Facilities. California

Medicine, Volume 109, pp. 191-197, 1968. 24. Smith DE. Acute and Chronic Marijuana Toxicity. Journal of Psychedelic Drugs, Volume 2, 1969. 25. Smith DE & Bentel DJ. California Drug Scene. The Yearbook of Drug Abuse, Behavioral Publications, New York, p. 157,

1969. 26. Schick F, Meyer FH & Smith DE. Marijuana Use in the Haight-Ashbury Subculture. Journal of Psychedelic Drugs,

Volume 2(1), 1969. 27. Smith DE & Mehl C. An Analysis of Marijuana Toxicity. Clinical Toxicology, March, 1970. 28. Smith DE. Runaways and Their Health Problems in the Haight-Ashbury During the Summer of 1967. American

Journal of Public Health, November, 1969. 29. Smith DE. The Characteristics of Dependence in High Dose Methamphetamine Abuse. International Journal of

Addictions, Volume 4(3), pp. 453-459, 1969. 30. Smith DE. Changing Drug Patterns in the Haight-Ashbury. California Medicine, February, 1969. 31. Smith DE. Speed Freaks vs. Acid Heads: A Conflict Between Drug Subcultures. Clinical Pediatrics, April, 1969.

32. Smith DE. Dependence Characteristics in High Dose Methamphetamine Abuse. International Journal of Addictions, 1969.

33. Smith DE. Youth, Alienation and the Drug Scene. American Journal of Osteopathy, 1969. 34. Smith DE, Wesson D & Lannon R. New Developments in Barbiturate Abuse. Drug Abuse Papers 1969, U.C. Berkeley

Extension, 1969. 35. Smith DE. Narcotics Abuse in San Francisco. Drug Abuse Papers 1969, U.C. Berkeley Extension, 1969. 36. Smith DE. LSD and the Psychedelic Syndrome. Clinical Toxicology, Volume 2(1), pp. 69-73, March, 1969. 37. Smith DE. Physical vs. Psychological Dependence and Tolerance in High Dose Methamphetamine Abuse. Clinical

Toxicology, Volume 2(1), pp. 99-103, March, 1969. 38. Smith DE. The Trip: There and Back. Emergency Medicine, December, 1969.


39. Smith DE & Sturges CS. The Semantics of the San Francisco Drug Scene. ETC, Volume 26(2), pp. 168-175, 1969. 40. Smith DE. & Fischer, CM. Acute Amphetamine Toxicity. Journal of Psychedelic Drugs, Volume 2(1), pp. 49-54, 1969. 41. Smith DE et al. Behavioral Mediators in the Polyphasic Mortality Curve of Aggregate Amphetamine Toxicity.

Journal of Psychedelic Drugs, Volume 2(2), pp. 28-36, 1969. 42. Smith DE. The Psychotomimetic Amphetamines with Special Reference to DOM Toxicity. Journal of Psychedelic

Drugs, pp. 37-41, 1969. 42a. Smith DE. An Analysis of Variables in High Dose Methamphetamine Dependence. Journal of Psychedelic Drugs,

Volume 2(2), pp. 60-62, 1969. 43. Schick JF, Smith DE & Meyer FH. The Use of Amphetamine in the Haight-Ashbury Subculture. Journal of Psychedelic

Drugs, pp. 139-171, 1969. 44. Smith DE & Sternfeld JL. Natural Childbirth and Cooperative Child Rearing in Psychedelic Communes. Excerpta

Medica, American Association of Planned Parenthood Physicians, April, 1969. 45. Smith DE & Wesson DR. New Developments in Barbiturate Abuse. Clinical Toxicology, Volume 3(1), pp. 57-65, 1970. 46. Smith DE & Sternfield JL. Natural Childbirth and Cooperative Child Rearing in Psychedelic Communes. Advances in

Planned Parenthood, Volume 4(1), 1970. 47. Smith DE & Sternfield JL. The Hippie Communal Movement: Effects on Childbirth and Development. American

Journal of Orthopsychiatry, Volume 40(3), April, 1970. 48. Smith DE & Wesson DR. A New Method for Treatment of Barbiturate Dependence. Journal of the American Medical

Association, Volume 213(2), pp. 294-295, February 13, 1970. 49. Smith DE, Luce J & Dernberg E. The Health of the Haight-Ashbury. Transaction, April 1970. 49a. Shick JFE & Smith DE. Analysis of the LSD Flashback. Journal of Psychedelic Drugs, Volume 3(1), pp. 13-19, 1970. 49b. Smith DE. LSD, Violence and Radical Religious Beliefs. Journal of Psychedelic Drugs, Volume 3(1), pp. 38-40, 1970. 49c. Smith DE & Rose AJ. The Group Marriage Commune: A Case Study. Journal of Psychedelic Drugs, Volume 3(1), pp. 115-119, 1970. 49d. Smith DE & Sternfield JL. Natural Childbirth and Cooperative Child Rearing in Psychedelic Communes. Journal of

Psychedelic Drugs, Volume 3(1), pp. 120-124, 1970. 50. Smith DE & Bentel DJ. A New Phenomenon Has Appeared: The Free Clinic. California Health, April, 1971. 51. Smith DE & Wesson DR. A Phenobarbital Technique for Withdrawal of Barbiturate Abuse. Archives of General

Psychiatry, January, 1971. 52. Bentel DJ & Smith DE. The Year of the Middle Class Junkie. California Health, April, 1971. 53. Sheppard C, Gay GR & Smith DE. Changing Patterns of Heroin Addiction in the Haight-Ashbury. Journal of

Psychedelic Drugs, Volume 3(2), 1971. 54. Bentel DJ & Smith DE. The Crisis of Drugs, Combat and the American Soldier in Vietnam. Synapse, Volume 15(28),

May, 1971.


55. Wesson DR & Smith DE. Barbiturate Use as an Intoxicant - A San Francisco Perspective. Testimony to be presented to the Subcommittee to Investigate Juvenile Delinquency, Washington D.C., December 15, 1971.

56. Wellisch DK, Gay GR, Wesson DR & Smith DE. The Psychotic Heroin Addict. Journal of Psychedelic Drugs, Volume

4(1), 1971. 57. Bentel DR & Smith DE. Drug Abuse in Combat: The Crisis of Drugs and Addiction Among American Troops in

Vietnam. Journal of Psychedelic Drugs, Volume 4(1), pp. 23-30, 1971. 58. Wesson DR, Gay GR & Smith DE. Treatment Techniques for Narcotic Withdrawal with Special Reference to Mixed

Narcotic-Sedative Addictions. Journal of Psychedelic Drugs, Volume 4(2), pp. 118-122, 1971. 59. Sheppard CW, Gay GR & Smith DE. Emergency Treatment of Acute Depressant Drug Overdose. Missouri Medicine,

pp. 109-111, February, 1972. 60. Smith DE, Newmeyer J, Gay GR & Corn R. Methadone for Kicking and for Kicks. Published for the 4th Annual

Methadone Conference, January 10, 1972. 61. Gay GR, Smith DE & Sheppard CW. Yesterday’s Flower Child is Today’s Junkie. Medical Insight, pp. 45-50, March,

1972. 62. Wesson DR, Gay GR & Smith DE. Managing Narcotic and Sedative Withdrawal. Hospital Physician, pp. 52-55,

January, 1972. 63. Schick JF & Smith DE. Analysis of the LSD Flashback. Journal of Psychedelic Drugs, Volume 3(1), 1972. 64. Smith DE. A Physician’s View of the Adolescent Drug Scene. Drug Abuse Proceedings of the International Conference,

pp. 271-275, 1972. 65. Smith DE. Sexual Practices in the Hippie Subculture. Medical Aspects of Human Sexuality, pp. 142-151, April, 1972. 66. Smith DE & Gay GR. Medical Care of Psychotropic Drug Problem Patients Outside the Hospital. World Medical

Journal, Volume 19(2), March-April, 1972. 67. Smith DE, Gay GR & Einstein S. Acute Drug Reactions in Perspective. The Non-Medical Use of Drugs: Contemporary

Clinical Issue, Number 1, pp. 47-55, 1972. 68. Shick JF, Smith DE & Wesson DR. The Illicit Use of the Psychotomimetic Amphetamines with Special Reference to

STP (DOM) Toxicity. Journal of Psychedelic Drugs, Volume 5(1), 1972. 69. Shick JF, Smith DE & Wesson DR. Amphetamine Toxicity with Analysis of Patterns of Use and Abuse. Journal of

Psychedelic Drugs, Volume 5(1), 1972. 70. Gay GR, Wesson DR, Smith DE & Sheppard CW. Outpatient Barbiturate Withdrawal Using Phenobarbital.

International Journal of Addictions, Volume 7(1), pp. 17-27, 1972. 71. Sheppard CW, Smith DE & Gay GR. The Changing Face of Heroin Addiction in the Haight-Ashbury. International

Journal of Addictions, pp. 109-123, 1972. 72. Smith DE. The Free Clinic. The Federal Challenge to the Community: A Health and Education Program for the

Prevention and Treatment of Drug Abuse and Addiction, Wadler et al, 1972. 73. Wesson DR, Gay GR & Smith DE. Clinical-Political Issues of Barbiturate Use and Abuse. Contemporary Drug

Problems, pp. 453-465, Summer, 1972.


74. Ramer BS, Smith DE & Gay GR. Adolescent Heroin Abuse in San Francisco. International Journal of the Addictions, Volume 7(3), pp. 461-465, 1972.

75. Newmeyer JA, Gay GR, Corn R & Smith DE. Methadone for Kicking and for Kicks. Fourth National Conference on

Methadone Treatment: Proceedings, National Association for the Prevention of Addiction to Narcotics (NAPAN), pp. 461-464, 1972.

76. Shick JF & Smith DE. The Illicit Use of the Psychotomimetic Amphetamines with Special Reference to STP (DOM)

Toxicity. Journal of Psychedelic Drugs, Volume 5(2), pp. 131-138, Winter, 1972. 77. Wesson DR & Smith DE. Recognizing and Treating Amphetamine Abuse. Hospital Physician, pp. 22-25, August, 1973. 78. Smith DE. Patterns of Drug Abuse in Industry. Drug Abuse in Industry, Published by Charles C. Thomas, Springfield,

pp. 49-55. 1973. 79. Shick JF, Smith DE & Wesson DR. An Analysis of Amphetamine Toxicity and Patterns of Use. Journal of Psychedelic

Drugs, Volume 5(2), pp. 113-130, Winter, 1973. 80. Smith DE & Case L. Drug Abuse. Family Practice Textbook, W.B. Saunders & Co., pp. 259-264, 1973. 81. Eiswirth NA, Smith DE & Wesson DR. Current Perspectives on Cocaine Use in America. Journal of Psychedelic Drugs,

Volume 5(2), pp. 159-166, 1973. 82. Wesson DR & Smith DE. Barbiturate Toxicity and the Treatment of Barbiturate Dependence. Journal of Psychedelic

Drugs, Volume 5(2), pp. 159-166, 1973. 83. Wesson DR & Smith DE. Methaqualone: Just Another Downer. Journal of Psychedelic Drugs, Volume 5(2), pp. 167-

170, 1973. 84. Wesson DR, Gay GR & Smith DE. The Politics of Barbiturate and Amphetamine Abuse. Journal of Psychedelic Drugs,

Volume 5(2), pp. 177-182, 1973. 85. Smith DE & Wesson DR. Legitimate and Illegitimate Distribution of Amphetamines and Barbiturates. Journal of

Psychedelic Drugs, Volume 5(2), pp. 177-182, 1973. 86. Smith DE, Loomis S, Jacobs-White L, Bricker B, Singleton J, Linda L. The Haight Ashbury Free Medical Clinic:

Approach to a Community Based Drug Rehabilitation Program. Vocational Rehabilitations of the Drug Abuser, Book 2, pp. 2-38, 1973.

87. Smith DE, Wesson DR & Ciceri R. The National Free Clinic Movement: Historical Perspective. ADIT, Volume 2(3),

pp. 1-2, 12-16, October, 1973. 88. Smith DE. The Free Clinic Movement in the United States. World Medical Journal, Volume 21(3), May-June, 1973. 89. Smith DE, Linda L, Loomis S, Jacobs-White L, Bricker B & Singleton J. A Community Based Drug Abuse

Rehabilitation Program in the Haight Ashbury. Preventive Medicine, Volume 2, pp. 529-542, 1973. 90. Smith DE & Wesson DR. Diagnosis and Treatment of Adverse Reactions to Sedative-Hypnotics. National Institute on

Drug Abuse Manual, No. 74-24, 1973. 91. Smith DE, Gay GR & Shepherd CW. The New Junkie. Emergency Medicine, Volume 6(2), pp. 117-126, February, 1974. 92. Smith DE & Wesson DR. Drugs of Abuse 1973: Trends and Developments. Annual Review of Pharmacology. Palo

Alto, CA, pp. 513-520, 1974.


93. Smith DE, Wesson DR & Linda L. Drug Crisis Intervention: Conceptual and Pragmatic Considerations. Journal of Psychedelic Drugs, Volume 6(2), April-June, 1974.

94. Smith DE. Street Drug Analysis and Community Based Drug Programs. Journal of Psychedelic Drugs, Volume 6(2),

April-June, 1974. 95. Smith DE & Wesson DR. A Conceptual Approach to Detoxification. Journal of Psychedelic Drugs. Volume 6(2), April-

June, 1974. 96. Smith DE, Loomis S & Linda L. Experiences of the Haight Ashbury Free Medical Clinic’s Community Based Drug

Program. Journal of Psychedelic Drugs, Volume 6(2), 1974. 97. Smith DE. The Evolution of Counter-Culture Street Drug Analysis Programs. Street Drug Analysis and Its Social and

Clinical Implications, The Addiction Research Foundation, pp. 1-8, Ontario, Canada, 1974. 98. Smith DE. West Coast Research/Findings Into Polydrug Abuse and Problems Associated with the Use of Non-

Opiates. Proceedings: 1974 Ohio Drug Studies Institute, Bureau of Drug Abuse, pp. 7-13, 1974. 99. Smith DE & Gay GR. The Development of Drug Patterns and Treatment Techniques in a Free Clinic. The Free Clinic

Handbook. Volume 30(1), pp. 127-142, 1974. 100. Smith DE, Wesson DR, Lerner SE & Kettner VR. Treatment of Polydrug Users in San Francisco. The American Journal

of Drug and Alcohol Abuse, Volume 1(2), pp. 159-179, 1974. 101. Smith DE & Wesson DR. Chronic Polydrug Abuse Among the “Non-Streetwise.” Newsletter, California Society for the

Treatment of Alcoholism and Other Drug Dependencies, Volume 2(1), January, 1975. 102. Smith DE & Gay GR. A Free Clinic Approach to Drug Abuse. Preventive Medicine, Volume 2, pp. 543-553, 1975. 103. Smith DE. The Role of the Free Clinic in America’s Changing Health Care Delivery System. Journal of Psychedelic

Drugs, Volume 7(1), January-March, 1975. 104. Smith DE. Special Treatment and Service Needs of Youthful Drug Abuses. Final Report: A Survey of New Techniques

for the Treatment of Drug Abusers, NIDA, Volume 2, Chapter 10, January, 1975. 105. Smith DE & Skeen E. Innovative Programming for the Drug Misusing Adolescent. Crime and Corrections: Journal of

the California Probation, Parole and Correctional Association, Volume 3(1), pp. 11-20, 1975. 106. Smith DE, Wesson DR & Yatsu FM. Amphetamine Abuse. Medical Aspects of Drug Abuse, pp. 50-56, 1975. 107. Smith DE & Wesson DR. Editor’s Note. Journal of Psychedelic Drugs, Volume 7(2), pp. 111-114, 1975. 108. Wesson DR, Smith DE & Lerner SE. Streetwise and Nonstreetwise Polydrug Typology: Myth or Reality. Journal of

Psychedelic Drugs, Volume 7(2), pp. 121-134, 1975. 109. Wesson DR, Smith DE & Lerner SE. The Treatment of the Polydrug Abuse in San Francisco with Discussion of Youth

and Polydrug Abuse. Catalog of Selected Documents in Psychology, Volume 5, American Psychological Association, pp. 228, 1975.

110. Smith DE. Community Approaches to Drug Abuse Treatment and Rehabilitation. Proceedings, Ohio Drug Studies

Institute, pp. 42-51, June, 1975.

111. Smith DE & DeRios MD. Using or Abusing? An Anthropological Approach to the Study of Psychoactive Drugs. Journal of Psychedelic Drugs, Volume 8(3), p. 263-266, 1976.


112. Smith DE. Rand Report Commentary. Newsletter, California Society for the Treatment of Alcoholism and Other Drug Dependencies, Volume 3(4), 1976.

113. Smith DE. The Free Clinic Movement in the United States: A Ten Year Perspective. Journal of Drug Issues:

Retrospective and Prospective. Part I, pp. 343-355, Fall, 1976. 114. Smith DE & Wesson DR. Managing the Barbiturate Withdrawal Syndrome. Acute Drug Abuse Emergencies, pp. 99-

104, 1976. 115. Smith DE & Wesson DR. An Analysis of Psychedelic Drug Flashbacks. American Journal of Drug and Alcohol Abuse,

Volume 3(3), pp. 425-438. 116. Smith DE & Wesson DR. Psychoactive Drug Crisis Intervention. Current Psychiatric Therapies, Volume 16, pp. 203-

208, 1976. 117. Smith DE. Multiple Substance Abuse - The New Face of Addiction. Contemporary Drug Problems: Proceedings of the

Ninth Annual Eagleville Conference, Volume 5(3), Fall, 1976. 118. Smith DE. The Disabled Physician. Proceedings for the 4th Annual Iowa Conference on Substance Use and Misuse, pp.

74-76, December 2-3, 1976. 119. Smith DE. Characteristics in Substance Abuse. Prescription Drugs and the Potential for Dependence, Exerpta Medica,

pp. 308, 1977. 120. Smith DE, Wesson DR, Kramer J, deRios M. Editor’s Note. Journal of Psychedelic Drugs, Volume 9(3), pp. 185-186,

July-September, 1977. 121. Smith DE & Wesson DR. Cocaine: Its Use for Central Nervous System Stimulation Including Recreational and

Medical Uses. Research Monograph Series 13: Cocaine 1977, National Institute on Drug Abuse, pp. 137-152, May, 1977. 122. Smith DE. Clinical Guidelines for Drug Detoxification. Gladman Psychiatric Hospital, Haight Ashbury Publications,

1977. 123. Smith DE. Lead Poisoning, Environmental Health and Social Class. The Mississippi Enterprise, Volume 45(42), p. 2,

July 30, 1977. 124. Smith DE. Treatment Techniques and the Dependent Physician. Helping the Impaired Physician. Proceedings of the

AMA Conference on “The Impaired Physician: Answering the Challenge”, pp. 49-54, February, 1977. 125. Smith DE & Seymour RB. The Haight Ashbury Free Medical Clinic: A Ten Year Perspective. San Francisco

Medicine, 1977. 126. Smith DE. Physician’s Attitudes Concerning Drug Abuse Treatment. Polydrug Abuse, The Results of a National

Collaborative Study, Academic Press, Inc., New York, 1978. 127. Smith DE & Wesson DR. Barbiturates and Other Sedative-Hypnotics. Treatment Aspects of Drug Dependence, pp. 117-

130, CRC Press, Inc., 1978. 128. Smith DE & Wesson DR. CNS Stimulants. Treatment Aspects of Drug Dependence, pp. 131-146, CRC Press, Inc., 1978. 129. Smith DE & Wesson DR. Psychedelics. Treatment Aspects of Drug Dependence, pp. 146-160, CRC Press, Inc., 1978.

130. Smith DE. Editor’s Note. Journal of Psychedelic Drugs, Volume 10(3), 1978.


131. Smith DE. A Clinical Approach to Diagnosis and Treatment of Amphetamine Abuse. Journal of Psychedelic Drugs, Volume 10(4), 1978.

132. Smith DE. Cocaine. Journal of Psychedelic Drugs, Volume 10(4), 1978. 133. Smith DE. Substance Abusing Physicians as Patients: Unique Aspects of Treatment. Conference Proceedings, March,

1978. 134. Smith DE. Editor’s Note. A Multicultural View of Drug Abuse, Proceedings of NDAC 77, G.K. Hall, 1978. 135. Smith DE, Cocaine Abuse: 1977. A Multicultural View of Drug Abuse. Proceedings of the NDAC77, G.K. Hall, pp. 116-

131, 1978. 136. Smith DE. The Practicing Physicians View of the Alcohol and Drug Abuse Patient: A Training and Consultation

Model for Analysis and Change. A Multicultural View of Drug Abuse, Proceedings of NDAC 77, G.K. Hall, pp. 246-262, 1978.

137. Smith DE, Levy SJ & Striar DE. Treatment Services for Youthful Drug Users. Youth Drug Abuse, Problems, Issues and

Treatment, pp. 537, 1978. 138. Smith DE, Wesson DR & Seymour RB. The Abuse of Barbiturates and Other Sedative-Hypnotics. Handbook on Drug

Abuse, National Institute on Drug Abuse and Executive Office of the President, Washington DC, 1979. 139. Smith DE & Seymour RB. The Enigma of Paraquat Contaminated Marijuana. The Street Pharmacologist, Volume

2(1), 1979. 140. Smith DE, Wesson DR, Seymour RB, Buxton ME & Kramer HM. The Diagnosis and Treatment of the PCP Abuse

Syndrome. Phencyclidine (PCP) Abuse: An Appraisal. National Institute on Drug Abuse, Rockville, Maryland, 1978. 141. Smith DE, Wesson DR, Seymour RB, Buxton ME & Kramer HM. The Diagnosis and Treatment of the PCP Abuse

Syndrome. Phencyclidine (PCP) Abuse: An Appraisal. National Institute on Drug Abuse, Rockville, Maryland, 1978. 142. Smith DE, Buxton ME & Dammann G. Amphetamine Abuse and Sexual Dysfunction: Clinical and Research

Considerations. Amphetamine Use, Misuse and Abuse, Proceedings of the National Amphetamine Conference 1978, G.K. Hall, pp. 228-250, 1979.

143. Chappel J, Smith DE & Buxton ME. Training Techniques for Physicians in the Diagnosis and Treatment of

Amphetamine Abuse. Amphetamine Use, Misuse and Abuse, Proceedings of the National Amphetamine Conference 1978, G.K. Hall, pp. 251-259, 1979.

144. Wesson DR & Smith DE. A Clinical Approach to Diagnosis and Treatment of Amphetamine Abuse. Amphetamine

Use, Misuse and Abuse, Proceedings of the National Amphetamine Conference 1978, G.K. Hall, pp. 260-276, 1979. 145. Smith DE & Wesson DR. Cocaine. Interamerican Seminary About Coca and Cocaine - Medical and Sociological Aspects.

pp., 49-61, Lima, Peru, July, 1979. 146. Smith DE. Drug Abuse Patterns on the West Coast. Proceedings, New York Academy of the Sciences Drug Abuse

Conference, December, 1979. 147. Smith DE. Importance of Gradual Dosage Reduction Following Low-Dose Benzodiazepine Therapy. Newsletter,

California Society for the Treatment of Alcoholism and Other Drug Dependencies, Volume 6(2), April, 1979. 148. Smith DE. Editor’s Note. Journal of Psychedelic Drugs, Volume 12(3-4), pp. 181-184, 1979.


149. Smith DE, Smith N, Buxton ME & Moser C. PCP and Sexual Dysfunction. Journal of Psychedelic Drugs, Volume 12(3-4), pp. 269-274, 1979.

150. Smith DE & Wesson DR. PCP Abuse: Diagnostic and Psychopharmacological Treatment Approaches. Journal of

Psychedelic Drugs, Volume 12(3-4), pp. 293-300, 1979. 151. Chappel J, Smith DE & Buxton ME. Paraprofessional and Professional Teamwork and Training in Managing PCP

and Other Drug Abuse Problems. Journal of Psychedelic Drugs, Volume 12(3-4), pp. 301-306, 1979. 152. Smith DE, Wesson DR & Linda L. Clinical Approaches to Acute and Chronic Intervention in the Sedative-Hypnotic

Abuser. Drugs in Relation to the Drug User -Critical Drug Issues, pp. 192-243, 1980. 153. Smith DE. Persian Heroin in the San Francisco Bay Area, 1977-1980: The New Wave? Newsletter, California Society

for the Treatment of Alcoholism and Other Drug Dependencies, Volume 7(2), April, 1980. 154. Seymour RB, Smith DE & Corhacchia HJ. Status of Drug Education Programs in the United States - 1980. Unity for

the 80’s: The Official Proceedings of the National Alcohol and Drug Coalition. The Hayworth Press, Inc. New York, 1980. 155. Smith DE & Seymour RB. Prescribing Practices: The Educational Alternative for Misprescribers. Proceedings of the

White House Conference on Prescription Drug Abuse, Washington DC, 1980. 156. Smith DE & Seymour RB. The Prescription of Stimulants and Anorectics. Frequently Prescribed and Abused Drugs:

Their Indications, Efficacy and Rational Prescribing. Medical Monograph Series, National Institute on Drug Abuse, Rockville, Maryland, 1980.

157. Smith DE. A Clinical Approach to the Treatment of PCP. PCP (Phencyclidine): Historical and Current Perspectives,

Chapter 22, NPP Books, Ann Arbor, Michigan, 1981. 158. Smith DE. Drugs and Sexual Function. Sexual Problems in Medical Practice, American Medical Association, Chapter 17,

pp. 211-242, 1981. 159. Smith DE. Prescription Drugs and the Alcoholic: The Benzodiazepines - Therapeutic and Dependence

Considerations. Proceedings of the Eisenhower Medical Center and the California Society for the Treatment of Alcohol and Other Drug Dependencies, pp. 42-48, Winter, 1981.

160. Smith DE. Polydrug Abuse and Comprehensive Treatment Intervention. National Clearinghouse for Drug Abuse

Information, Rockville, Maryland, 1981. 161. Smith DE & Buxton ME. Women and Substance Abuse: Treatment Issues. Women in Crisis, Human Sciences Press,

Chapter 12, pp. 101-107, New York, 1981. 162. Smith DE & Buxton RB. Psychedelics. The Patient with Alcoholism and Other Drug Problems: A Clinical Approach for

Physicians and Helping Professionals, Yearbook Medical Publishers, Chicago, Illinois, 1981. 163. Smith DE & Seymour RB. Clinical Perspectives on the Toxicity of Marijuana, 1967-1981. Marijuana and Youth:

Clinical Observations on Motivation and Learning, National Institute on Drug Abuse, Rockville, Maryland, 1982. 164. Seymour RB, Smith DE & Gorton JG. The Client with a Substance Abuse Problem. Practice and Management of

Psychiatric Emergency Room Care, C.V. Mosby Company, St. Louis, Missouri, 1982. 165. Smith DE. Sedative Misuse and Dependence. The Patient with Alcohol and Drug Abuse Problems. C. Whitfield, pp. 33-

354, 1982. 166. Smith DE. Editor’s Introduction. Proceedings, Volume 14(1-2), January-June, 1982.


167. Smith DE. A Clinical Guide to the Diagnosis and Treatment of Heroin-Related Sexual Dysfunction. Proceedings, Volume 14(1-2), January-June, 1982.

168. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Amphetamine Look-Alikes. High Times,

Number 80, p. 30, April, 1982. 169. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Glutethimide and Codeine. High Times, Number

81, p. 30, June, 1982. 170. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Persian Heroin. High Times, Number 82, p. 30,

June, 1982. 171. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Alpha Metyl Fentanyl. High Times, Number 83,

p. 30, June, 1982. 172. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Cocaine Freebase. High Times, Number 84,

August, 1982. 173. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Lysergic Acid Diethylamide. High Times,

Number 85, September, 1982. 174. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Marijuana. High Times, Number 86, October,

1982. 175. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Alcohol. High Times, Number 87, November,

1982. 176. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Valium. High Times, Number 88, December,

1982. 177. Smith DE & Seymour RB. Clinical Perspectives on the Toxicity of Marijuana, 1967-1981. Marijuana and Youth:

Clinical Observations on Motivation and Learning, U.S. Department of Health and Human Services Publication, Washington DC, pp. 61-72, 1982.

178. Smith DE, Seymour RB & Gorton JG. The Client With a Substance Abuse Problem. Practice and Management of

Psychiatric Emergency Care, C.V. Mosby Company, St. Louis, Missouri, 1982. 179. Smith DE & Yeary J. Dealing With Family Problems Caused by Alcohol. Medical Aspects of Human Sexuality, Volume

16(11), November, 1982. 180. Smith DE. Diazepam as Black Market Quaaludes. Newsletter, California Society for the Treatment of Alcoholism and

Other Drug Dependencies, Volume 9(3-4), October, 1982. 181. Smith DE. Diagnosis and Treatment of Cocaine Abuse. Proceedings, Symposium on Cocaine Abuse, New York State

Division of Substance Abuse Services Narcotic Drug Research, Inc., May, 1982. 182. Buffum J, Moser C & Smith DE. Street Drugs and Sexual Function. Handbook of Sexology: The Pharmacology and

Endocrinology of Sexual Functions, Elsevier Scientific Publications, pp. 462-477, 1982. 183. Smith DE & Seymour RB. Prescribing Psychoactive Drugs: A Question of Perspective. Society and Medication:

Conflicting Signals of Prescribers and Patients, Lexington Books, Lexington, 1983. 184. Smith DE. Treatment Considerations with Cocaine Abusers. Cocaine: A Second Look, American Council on Marijuana,

1983.


185. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Benzodiazepines. High Times, No. 89, January, 1983.

186. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Acupuncture and Addiction. High Times, No. 90, February, 1983.

187. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; MDA. High Times, No. 90, March, 1983. 188. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Amphetamines. High Times, No. 91, April, 1983. 189. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Psilocybin. High Times, No. 92, May, 1983. 190. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Talwin and Tripelennamine. High Times, No. 93,

June, 1983. 191. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Amyl, Butyl and Isobutyl Nitrite. High Times,

No. 94, July, 1983. 192. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Phencyclidines. High Times, No. 95, August,

1983. 193. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; AIDS, Part 1. High Times, No. 96, September,

1983. 194. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; AIDS, Part 2. High Times, No. 97, October, 1983. 195. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Nicotiana Tabacum. High Times, No. 98,

November, 1983. 196. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Caffeine. High Times, No. 99, December, 1983. 197. Smith DE. Intervention Techniques for the Physician with a Substance Abuse Disorder. San Francisco Medicine, San

Francisco Medical Society, September, 1983. 198. Smith DE. Benzodiazepine Dependency Syndromes. Proceedings, Volume 15(1-2), 1983. 199. Smith DE. Diagnostic, Treatment and Aftercare Approaches to Cocaine Abuse. Journal of Substance Abuse Treatment,

Volume 1(1), 1984. 200. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; D.O.B. High Times, No. 100, January, 1984. 201. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Cocaine. High Times, No. 101, February, 1984 202. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Cocaine Look Alikes. High Times, No. 102,

March, 1984. 203. Smith DE. Substance Abuse Disorders: Drugs and Alcohol. Review of General Psychiatry, Lange Medical Publishers,

Los Altos, California, 1984. 204. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; MPTP. High Times, No. 103, April, 1984. 205. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Heroin. High Times, No. 104, May, 1985. 206. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Volatile Hydrocarbons. High Times, No. 105,

June, 1984.


207. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Methaqualone. High Times, No. 106, July, 1984. 208. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Barbiturates. High Times, No. 107, August, 1984 209. Smith DE & Seymour RB. Abuse Folio: High Times Desk Reference; Mescaline/Peyote. High Times, No. 108,

September, 1984. 210. Smith DE. Sexual Effects of Illicitly Used Drugs. Physician and Patient, Volume 3(5), May, 1984. 211. Smith DE. Benzodiazepine Dependence Potential: Current Studies and Trends. Journal of Substance Abuse Treatment,

1984. 212. Smith DE. Look Alike Drugs and Drugs of Deception: Epidemiological, Toxicological and Clinical Considerations,

1984. 213. Smith DE, Apter-Marsh M, Buffum J, Moser C & Wesson DR. Socio-Sexual Issues in the Using and Recovering

Alcoholic. Alcoholism Treatment Quarterly, Volume 1(3), Fall, 1984. 214. Smith DE & Wesson DR. Substance Abuse in Industry: Intervention, Treatment and Prevention. Substance Abuse

in the Workplace, Haight Ashbury Publications, San Francisco, 1984. 215. Smith DE. Cocaine and Alcohol Induced Sexual Dysfunction. Proceedings, Volume 16(1-2), October-December, 1984. 216. Smith DE, Milkman H & Sunderwirth S. Addictive Disease: Concept and Controversy. The Addictions. Lexington

Books, Lexington, Massachusetts, 1984. 217. Seymour RB & Smith DE. A Clinical Update on Illicit and Prescription Drugs - 1984. San Francisco Medicine, 1984. 218. Smith DE & Seymour RB. Marijuana, Addictive Disease and Recovery. Drug Use in Society: Proceedings of Marijuana

and Health Conference, Council on Marijuana and Health, Washington DC, 1984. 219. Smith DE. Controversies Surrounding the Emergence of Addictionology as a Specialty. Newsletter, California Society

for the Treatment of Alcoholism and Other Drug Dependencies, June, 1985. 220. Smith DE, Seymour RB, Morgan JP & Kagan DV. Prescription Psychoactive Drugs: A Question of Perspective. Social

and Medical Signals for Prescribers and Patients, Chapter 16, 1985. 221. Smith DE & Seymour RB. The Dream Becomes a Nightmare: Adverse Reactions to LSD. Journal of Psychoactive

Drugs, Volume 17(4), 1985. 222. Smith DE & Seymour RB. Clarification of Designer Drugs. The U.S. Journal of Drug and Alcohol Abuse, November,

1985. 223. Smith DE. Look-Alike Drugs and Drugs of Deception: Epidemiological, Toxicological and Clinical Considerations.

Phenylpropanolamine: Risks, Benefits and Controversies, Volume 5, 1985. 224. Smith DE & Seymour RB. Nonmedical Prescription Drug Use. Topics in Clinical Pharmacology and Therapeutics, 1985. 225. Smith DE. 1984: A Clinical Update on Illicit and Prescription Drug Abuse. San Francisco Medicine, San Francisco

Medical Society, January, 1985. 226. Smith DE & Wesson DR. MDMA: Ecstasy as an Adjunct to Psychotherapy and a Street Drug of Abuse. California

Society for the Treatment of Alcoholism and Other Drug Dependencies News, September, 1985.


227. Smith DE & Seymour RB. A Clinical Approach to the Impaired Health Professional. The International Journal of the Addictions. Volume 20(5), pp. 713-722, 1985.

228. Smith DE, Seymour RB. Focus on Illicit Drugs: Clarification of Designer Drugs, U.S Journal of Alcohol and Chemical

Dependence, November, 1985. 229. Smith DE, Wesson DR, Camber S & Harley M. Diazepam and Desmethyldiazepam in Breast Milk. Journal of

Psychoactive Drugs, Volume 17(1), pp. 55-56, January-March, 1985. 230. Smith DE. Cultural Contrasts in Drug Abuse. U.S. Journal of Alcohol and Chemical Dependence, p. 7, December, 1986. 231. Smith DE, Havassy BE & Wesson DR. Theories of Relapse and Recovery and Their Implications of Drug Abuse

Treatment. Relapse and Recovery in Drug Abuse. NIDA Research Monograph 72, 1986. 232. Zweben JE & Smith DE. Changing Attitudes and Policies Toward Alcohol Use in the Therapeutic Community.

Journal of Psychoactive Drugs, Volume 18(3), 253-259, 1986. 233. Smith DE. Cocaine-Alcohol Abuse: Epidemiological, Diagnostic and Treatment Considerations. Journal of

Psychoactive Drugs, Volume 1, 1986. 234. Smith DE & Seymour RB. Look Alike Drugs, Drugs of Deception and Designer Drugs. The Narc Officer, Official

Publications of the International Narcotics Enforcement Officers Association, Spring, 1986. 235. Smith DE & Wesson DR. Substance Abuse in Industry: Identification, Intervention, Treatment and

Prevention. The Narc Officer, Spring, 1986. 236. Wesson DR, Smith DE & Morgan JP. The International Scheduling of OTC Inhaler Ingredients: An Abuse

Perspective. Journal of Psychoactive Drugs, Volume 18(2), pp. 151-154, 1986. 237. Smith DE & Seymour RB. Look Alike Drugs, Drugs of Deception and Designer Drugs. The Narc Officer, pp. 57-62,

Spring, 1986. 238. Smith DE, Wesson DR & Gold MS. Cocaine Abuse and Treatment: A Starting Point. Psychiatry Letter, Volume 4(11),

pp. 55-64, 1986. 239. Smith DE & Seymour RB. Barbiturate/Sedative/Hypnotic. Psychiatric Treatment Manual, American Psychiatric

Association, New Haven, Connecticut, 1986. 240. Smith DE & Seymour RB. Non Medical Prescription Drug Use. Topics in Clinical Pharmacology and Therapeutics.

Springer-Verlag, Inc, New York, 1986. 241. Smith DE. Chemical Dependency and AIDS. AIDS and Chemical Dependency Forum, San Francisco, California, April,

1986. 242. Wesson DR, Smith DE & Morgan JP. International Scheduling of the OTC Inhaler Ingredients: An Abuse

Perspective. Journal of Psychedelic Drugs, Volume 18(2), pp. 151-54, April-June, 1986. 243. Smith DE. Role of Substance Abuse Professionals in the AIDS Epidemic. written for the American Medical Society of

Alcohol and other Drug Dependence, February, 1987. 244. Landry MJ & Smith DE. Crack: Anatomy of an Addiction. California Nursing Review, Volume 9(2), pp. 8-47, 1987. 245. Buxton ME, Smith DE & Seymour RB. Spirituality and Other Points of Resistance to the 12 Step Recovery Process.

Journal of Psychoactive Drugs, Volume 19(3), pp. 275-286, 1987.


246. Smith DE, Apter-Marsh M, Buffum J, Moser C & Wesson DR. Recovering Alcoholics in Family Practice. Medical Aspects of Human Sexuality, pp. 86-94, July, 1987.

247. Smith DE. Alcoholism, Recovery & Sexual Dysfunction. Psychiatric Medicine, Volume 3(3), pp. 163-172, 1987. 248. Smith DE. Teach, Bleach & Treat: AIDS Outreach. Medical Society of Addiction Medicine Conference, 1987. 249. Smith DE. Role of the Hospital Well Being Committee. San Francisco Medicine, pp. 25-40, January, 1987. 250. Smith DE & Landry MJ. AIDS and Chemical Dependency: An Overview. Journal of Psychoactive Drugs, Volume 20(2),

April-June, 1988. 251. Smith DE. Should the U.S. Legalize Narcotics? U.S. Journal of Alcohol and Chemical Dependence, Volume 12(8),

August, 1988. 252. Smith DE & Heilig S. Addiction Update 1988: Treatable Diseases. San Francisco Medicine, Volume 32(2), August,

1988. 253. Landry MJ & Smith DE. AIDS and Chemical Dependency: An Overview. Journal of Psychoactive Drugs, Volume

20(2), pp. 141-147, 1988. 254. Smith DE, Wesson DR, Sees KL & Morgan JP. An Epidemiological and Clinical Analysis of Propylhexedrine Abuse in

the United States. Journal of Psychoactive Drugs, Volume 20(4), pp. 441-442, 1988. 255. Smith DE & Wesson DR. Substance Abuse in Industry: Identification, Intervention, Treatment and Prevention, 1988. 256. Smith DE & Landry MJ. Psychoactive Substance Use Disorders: Drugs and Alcohol. General Psychiatry, Second

Edition, pp. 266-285, 1988. 257. Smith DE & Seymour RB. Clinical Issues on Drugs and the Law. Perspectives on Drug Abuse - Volume 1, Freund

Publishing House, Tel Aviv, 1988. 258. Smith DE. The Addictive Disease: Controversy and Understanding. Conference Address, 1989. 259. Smith DE & Seymour RB. The Evolution of Drug Use: The Changing Street Drug Scene. California Pharmacist,

August, 1989. 260. Smith DE. From the 60’s to the 90’s: The Evolution of Chemical Dependency Treatment. The Counselor, September-

October, 1989. 261. Smith DE. Hazards of Cocaine Becoming Notorious. U.S. Journal of Alcohol and Chemical Dependence, Volume 13(5),

May, 1989. 262. Smith DE & Zweben, JE. Considerations in Using Psychotropic Medicine with Dual Diagnosis Patients in Recovery.

Journal of Psychoactive Drugs, Volume 21(2), pp. 221-228, April-June, 1989. 263. Smith DE & Heilig S. Addiction Medicine Alert. San Francisco Medicine, Volume 19, November, 1989. 264. Smith DE, Wesson DR, Camber S & Landry MJ. Perceptions of Benzodiazepine and Cocaine Abuse by US Addiction

Specialists. National Directorate for Prevention of Alcohol and Drug Problems, Volume 4, pp. 371-390, 1989. 265. Smith DE, Wesson DR & Landry MJ. The Pharmacology of Benzodiazepine Addiction. Selective Therapeutic Index,

Volume 2(9), pp. 94-107, September, 1989. 266. Smith DE. Addiction Medicine and Primary Care. Western Journal of Medicine, May, 1990.


267. Smith DE & Wesson DR. Prescription Drug Abuse: Patient, Physician and Cultural Responsibilities. Western Journal

of Medicine, Volume 152, pp. 613-616, May 1990. 268. Landry MJ & Smith DE. Benzodiazepine Dependency Discontinuation: Focus on the Chemical Dependency

Detoxification Setting and Benzodiazepine Polydrug Abuse. Journal of Psychoactive Drugs, Volume 24(2), pp. 145-156, 1990.

269. Seymour RB & Smith DE. Identifying and Responding to Drug Abuse in the Workplace: An Overview. Journal of

Psychoactive Drugs, Volume 22(4), 1990. 270. Smith DE & Seymour RB. Psychoactive Substance Use Disorders. Continuum Encyclopedia of Counseling, Continuum

Publishing Group, New York, 1991. 271. Smith DE & Seymour RB. Benzodiazepines. Comprehensive Handbook of Drug and Alcohol Addiction, Marcel Dekker,

Inc., New York, 1991. 272. Seymour RB & Smith DE. Hallucinogens. Comprehensive Handbook of Drug and Alcohol Addiction, Marcel Dekker, Inc.,

New York, 1991. 273. Smith DE, Ehrlich P & Seymour RB. Current Trends in Adolescent Drug Use. Psychiatric Annals, Volume 21(2), 1991. 274. Landry MJ, Smith DE, McDuff D, et al. Anxiety and Substance Abuse Disorders: A Primer for Primary Care

Physicians. American Journal of Family Practice, Volume 4(1), pp. 447-456, July, 1991. 275. Landry M, Smith DE, McDuff D, et al. Anxiety and Substance Abuse Disorders: The Treatment of High Risk Patients.

American Journal of Family Practice, Volume 4(1), pp. 447-456, July, 1991. 276. Smith DE & Seymour RB. Psychoactive Substance Use Disorders. Continuum Encyclopedia of Counseling. Continuum

Publishing Group, New York, 1991. 277. Zweben JE, Smith DE & Stewart P. Psychotic Conditions and Substance Abuse Use: Prescribing Guidelines and Other

Treatment Issues. Journal of Psychoactive Drugs, Volume 23(4), 1991. 278. Landry MJ, Smith DE & Steinberg JR. Anxiety, Depression and Substance Abuse Disorders: Diagnosis, Treatment

and Prescribing Practices. Journal of Psychoactive Drugs, Volume 23(4), 1991. 279. Wesson DR, Smith DE & Seymour RB. Sedative-Hypnotics and Tricyclics. Substance Abuse: A Comprehensive

Textbook. Williams and Wilkins, Baltimore, Maryland, 1991. 280. Landry MJ, Smith DE, McDuff DR & Baughman OL. Benzodiazepine Dependence and Withdrawal: Identification and

Medical Management. Journal of Family Practice, Volume 5(2), 1992. 281. Smith DE, Lusher T & Seymour RB. Benzodiazepines and Other Sedative-Hypnotic Detoxification. Manual of the

Detoxification of the Pregnant Addict. Department of Health Services, State of California, 1992. 282. Seymour RB, Smith DE & Ehrlich P. Counseling the Adolescent Drug Abuse Client. Plenum Publishing Corporation,

New York, 1993. 283. Smith DE & Seymour RB. Drugs in the Workplace. Occupational Health and Safety, National Safety Council, Itasca,

Illinois, 1992. 284. Seymour RB & Smith DE. Crack Cocaine: Prevention, Intervention & Spirituality. Treatment Centers Magazine,

1993.


285. Wesson DR, Smith DE & Seymour RB. Sedative Hypnotics and Tricyclics. Synopsis of Substance Abuse. Williams and Wilkins, Baltimore, 1993.

286. Wesson DR, Smith DE & Seymour RB. Sedative-Hypnotics and Tricyclics. Clinical Handbook of Substance Abuse.

Williams and Wilkins, Baltimore, 1993. 287. Smith DE, Buxton ME, Bilal R & Seymour RB. Cultural Points of Resistance to the Twelve Step Recovery Process.

Journal of Psychoactive Drugs, 1993. 288. Wesson DR, Ling W & Smith DE. Prescription of Opioids for Treatment of Pain in Patients with Addictive Disease.

Journal of Pain and Symptom Management, Volume 8(5), pp. 289-296, July, 1993. 289. Smith DE, Wesson DR & Ling W. Treatment of Multiple Drug/Alcohol Intoxication and Withdrawal. ASAM

Principles of Addiction, ASAM, 1993. 290. Wesson DR, Smith DE & Washburn P. Medical Aspects of Chemical Dependency. Hazelden, 1993. 291. Seymour RB & Smith DE. The Psychedelic Resurgence. Hazelden, 1993.

292. Morrison MA, Smith DE, Wilford B, Ehrlich, P & Seymour RB. At War in the Fields of Play: Current Perspectives on

the Nature and Treatment of Adolescent Chemical Dependency. Journal of Psychoactive Drugs, Volume 25(4), October-December, 1993.

293. Smith DE. Haight Ashbury Revisited. Proceedings of the Hallucinogens, LSD and Raves Symposium, National Press Club,

November, 1993. 294. Wesson DR & Smith DE. Benzodiazepines and Other Sedative-Hypnotics. Textbook of Substance Abuse Treatment. The

American Psychiatric Press, pp. 179-190, 1994. 295. Smith DE. AA Recovery and Spirituality: An Addiction Medicine Perspective; Response Paper. Journal of Substance

Abuse Treatment, Volume 11(2), pp. 111-112, 1994. 296. Wesson DR, Ling W, Smith DE. Zolpidem: An Addiction Medicine Perspective. California Society of Addiction

Medicine News, Spring, 1994. 297. Wesson DR, Smith DE & Ling W. Prescription Drug Abuse and Addiction. Hazelden Educational Materials, Center

City, MN, 1994. 298. Smith DE & Seymour RB. LSD: History and Toxicity. Psychiatric Annals, Volume 24(3), pp. 145-147, March, 1994. 299. Smith DE & Wesson DR. Benzodiazepine and Other Sedative-Hypnotic Dependence. Treatment of Psychiatric

Disorders, Second Edition, American Psychiatric Press, Volume 1, pp. 673-683. 300. Smith DE, Wesson DR & Calhoun SR. Rohypnol: Quaalude of the Nineties? CSAM News, Summer 1995, Volume 22,

No. 2. 301. Smith DE, Galloway GP, Frederick SL, Gonzales M, Stalcup SA & Staggers FE. Gammahydroxybutyrate: A

Neurotransmitter of Abuse? California Society of Addiction Medicine Newsletter, Summer 1996, Volume 23, Number 1. 302. Smith DE, Galloway GP, Wesson DR, Calhoun SR. Update on Rohypnol: Abuse Patterns in Texas. Vol. 23, #2,

California Society of Addiction Medicine Newsletter,Fall 1996, Volume 23, Number 2. 303. Calhoun SR, Wesson DR, Galloway GP, Smith DE. Abuse of Flunitrezepam (Rohypnol) and other Benzodiazepines in

Austin and Southeast Texas. Journal of Psychoactive Drugs, April-June 1996, Volume 28, Number 2, pp. 183-189.


304. Smith DE, Galloway GP, Newmeyer J, Knapp T, Stalcup SA. A Controlled Trial of Imipramine for the Treatment of Methamphetamine Dependence. Accepted pending revisions, Journal of Substance Abuse Treatment.

305. Smith DE, Galloway GP, Frederick SL, Staggers FE, Gonzalez M, Stalcup SA. Gammahydroxybutyrate: An Emerging

Drug of Abuse that Causes Physical Dependence. Addiction. 92(1), 89-96, 1997 306. Smith DE, Galloway GP, Seymour RB. Methamphetamine: An Old Problem Returns. American Society of Addiction

Medicine News. 11(1): 6-7, 1996. 307. Smith DE, Frederick SL, Galloway GP, Staggers FE, Stalcup SA. Gammahydroxybutyrate: A Putative

Neurotransmitter That is Abused and Causes Physical Dependence. in Harris, LS (ed): Problems of Drug Dependence, 1994: Proceedings of the 56th Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc. Rockville, MD. National Institute on Drug Abuse, 1996.

308. Smith DE, Miller NS & Gold MS. Manual of Therapeutics for Addictions. John Wiley & Sons, Inc. 1997. 309. Smith DE. The 1995 Distinguished Lecturer in Substance Abuse. Journal of Substance Abuse Treatment. Vol. 13(4), pp.

289-294, 1996. 310. Smith DE & Seymour, RB. Benzodiazepine: Disintossicazione. Medicine delle Tossicodipendenze (Italian Journal of the

Addictions). Vol. 5, 1-2, 1997 311. Smith DE, Galloway GP, Newmeyer J, Knapp T, Stalcup SA. A Controlled Trial of Imipramine for the Treatment of

Methamphetamine Dependence. Journal of Substance Abuse Treatment, Vol. 13, pp. 493-497, November, 1996. 312. Smith DE & Miller NS. The Integration of Pharmacotherapy and Nonpharmacotherapy. Journal of Addiction

Diseases. Volume 16, pp. 51-64, Number 4, 1997. 313. Smith DE & Seymour RB. Addiction Medicine and the Free Clinic Movement. Journal of Psychoactive Drugs. Volume

29, pp. 155-160, April-June, 1997. 314. Smith DE & Seymour RB. The Many Meanings of Free. Humanism in the Health Sciences. Volume 2, pp. 6-7, Fall,

1997. 315. Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 4(6), November-December, 1997. 316. Seymour, RB, Smith DE. Treatment of Protracted Drug-Induced Syndromes. In Norman S. Miller, MD, ed. The

Principles and Practice of Addictions in Psychiatry. W.B. Saunders Company, Philadelphia, 1997. 317. Smith, DE & Seymour, RB. Cannabis and Cannabis Withdrawal. Journal of Substance Misuse, 2(1), 1997. 318. Smith, DE, Galloway, GP & Seymour, RB. Methamphetamine Abuse and Treatment. Valparaiso University Law

Review, 1997. 319. Seymour, RB & Smith, DE. Benzodiazepine Use and Misuse. Medicina delle Tossicodipendenze (The Italian Drug Abuse

Journal), 1997. 320. Smith, DE & Seymour, RB. Advances in Anticraving Agents: Adjunctive Use of Medication Continues as Relapse

Prevention Strategy. Employee Assistance, 8(4), 1996 321. Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 5(1), January-February, 1998. 322. Smith, DE & Seymour, RB. International Addictions Update. Journal of Psychoactive Drugs. Volume 30(1), pp. 111-

117, January-March, 1998.


323. Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 5(2), March-April, 1998, p. 7. 324. Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 5(3), May-June, 1998, p. 7. 325. Smith, DE. Review of the AMA Council on Scientific Affairs Report on Medical Marijuana. Journal of Psychoactive

Drugs. Volume 30(2), pp. 127-136, April-June, 1998. 326. Calhoun, SR, Galloway, G & Smith, DE. Abuse Potential of Dronabinol (Marinol®). Journal of Psychoactive Drugs.

Volume 30(2), pp. 187-196, April-June, 1998. 327. Smith, DE, Ehrlich, P & Seymour, R. Current Trends in Adolescent Drug Use. San Francisco Medicine. Volume 71(5),

pp. 22-23, 26, June, 1998. 328. Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 5(4), July-August, 1998, p. 7. 329. Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 5(5), September-October, 1998, p.7. 330. Smith, DE, Lawlor B, & Seymour, RB. Health Care at the Crossroads. San Francisco Medicine, 69(6), 1996. 331. Seymour, RB, Smith DE. Cannabis Addiction and Withdrawal: Attitudes and Implications. In David T. Brown, ed.

Cannabis, The Genus Cannabis, OPA (Overseas Publishers Association), Harwood Academic Publishers, Amsterdam, 1998. 332. Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 5(6), November-December, 1998, p. 7. 333. Wesson, D, Smith, DE, Ling, W. Pharmacologic Therapies for Benzodiazepine and other sedative-hypnotic addiction.

Principles of Addiction Medicine, second ed. 517-530, 1998. 334. Smith DE & Wesson DR. Benzodiazepine and Other Sedative-Hypnotic Dependence. Textbook of Substance Abuse

Treatment, Second Edition. Galanter, M & Kleber, HD, eds., American Psychiatric Press, pp. 239–250, 1999. 335. Seymour, RB & Smith, DE. Psychological and Psychiatric Consequences of Hallucinogens. Handbook of Substance

Abuse: Neurobehavioral Pharmacology. RE Tarter, RT Ammerman & PJ Ott, eds., pp. 241–251, Plenum Press, 1998. 336. Smith, DE & Seymour, RB. Overcoming Cultural Points of Resistance to Spirituality in the Practice of Addiction

Medicine. Addiction and Spirituality: A multidsciplinary Approach. Morgan, OJ, & Jornan, M., eds., pp. 95–109, Chalice Press, 1999.

337. Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 6(1), January-February, 1999, p.7. 338. Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 6(2), March-April, 1999, p. 7. 339. Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 6(3), May-June 1999, p. 7. 340. Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 6(4), July-August, 1999, p. 7. 341. Smith, DE & Seymour RB. Ask Dr. Dave. New Times. Volume 6(5), September-October, 1999, p.7. 342. Smith, D & Heilig, S. “Medicalizing” American Drug Policy—A Much-Needed Focus on Prevention & Treatment.

San Francisco Medicine, Volume 72 (10), pp. 28–30, November/December, 1999. 343. Smith, DE, Glatt, W, Tucker, DE, Deutsch, R, Seymour, R. Drug Testing in the Workplace: Integrating Medical

Review Officer Duties into Occupational Medicine. Occupational Medicine: State of the Art Reviews, Volume 17(1), pp. 79-90, January-March 2002.


344. Ling, W & Smith, DE. Buprenorphine: blending practice and research. Journal of Substance Abuse Treatment, Volume 23(2002), pp. 87-92.

345. Ling, W, Wesson, DR, Smith, DE. Prescription Opiate Abuse. Substance Abuse: A Comprehensive Textbook, Lowinson,

JH, Ruiz, P, Millman, RB, Langrod, JG, eds. pp. 459-468, Lippincott, Williams & Wilkins, 2005. 346. Wesson, DR, Smith, DE, Ling, W, Seymour, RB. Sedative-Hypnotics. Substance Abuse: A Comprehensive Textbook,

Lowinson, JH, Ruiz, P, Millman, RB, Langrod, JG, eds. pp. 302-313, Lippincott, Williams & Wilkins, 2005.

347. Wilford, B, Smith, DE, Bucher, R. Prescription Stimulant Sales on the Internet. Psychiatric Annals, Volume 35 (3), pp. 241-252, March, 2005.

348. Coleman, JJ, Bensinger, PB, Gold, MS, Smith, DE, Bianchi, RP, DuPont, RL. Can Drug Design Inhibit Abuse? Journal of

Psychoactive Drugs, Volume 37 (4). pp. 343- 362, December, 2005. 349. Smith, DE. An Upper/Downer Perfect Storm: The Coming World- Wide Drug Epidemic. Journal of Psychoactive

Drugs, Volume 38 (4). pp. 535-536, December, 2006.

350. Wesson, DR, Smith, DE, Ling, W, Sabnani, S. Substance abuse: sedative, hypnotic, or anxiolytic use disorders. In: Tashman, A, Kay, JA, Lieberman, J, First, MB, Maj, M, eds. Psychiatry. Vol 1. Third ed. Chichester, Engalnd: John Wiley & Sons; 2008:1187-1200.

XV. Journal Theme Editor

1. Smith DE, Editor. Psychedelic Drugs and The Law. Proceedings, Volume 1(1), 1967. 2. Smith DE, Editor. Psychedelic Drugs and Religion. Journal of Psychedelic Drugs, Volume 1(2), 1967. 3. Smith DE, Editor. Current Marijuana Issues. Journal of Psychedelic Drugs, Volume 2(2), 1969. 4. Smith DE, Editor. Amphetamine Abuse. Journal of Psychedelic Drugs, Volume 2(2), 1969. 5. Smith, DE, Editor. LSD: The Psychedelic Experience and Beyond. Journal of Psychedelic Drugs, Volume 3(1), 1970. 6. Smith DE & Gay GR, Editors. The Contemporary Heroin Scene, Part I: The Problem. Journal of Psychedelic Drugs,

Volume 4(2), 1971. 7. Smith DE, Editor. The Contemporary Heroin Scene, Part II: Treatment. Journal of Psychedelic Drugs, Volume 4(2),

1972. 8. Smith DE, Editor. Drug Abuse 1972. Journal of Psychedelic Drugs, Volume 5(1), 1973. 9. Smith DE & Wesson DR, Editors. The Politics of Uppers and Downers. Journal of Psychedelic Drugs, Volume 5(2),

1973. 10. Smith DE & Wesson DR, Editors. Drug Abuse 1973. Journal of Psychedelic Drugs, Volume 6(1), 1974. 11. Smith DE & Wesson DR, Editors. Community Approaches to Drug Treatment and Rehabilitation. Journal of

Psychedelic Drugs, Volume 6(2), 1974. 12. Smith DE & Wesson DR, Editors. Polydrug Abuse. Journal of Psychedelic Drugs, Volume 8(2) 1975.


13. Smith DE, Wesson DR & Bourne P, Editors. Innovative Approaches to Drug Abuse Treatment. Journal of Psychedelic Drugs, Volume 8(3), 1976.

14. Smith DE, Editor. Drugs, History and Culture. Journal of Psychedelic Drugs, Volume 9(3), 1977. 15. Smith DE, Editor. Stimulant Use, Misuse: A Ten Year Follow Up. Journal of Psychedelic Drugs, Volume 10(4), 1978. 16. Smith DE, Editor. PCP: Problems and Prevention. Selected Proceedings of the National PCP Conference, Journal of

Psychedelic Drugs, Volume 12(3-4), 1980. 17. Smith DE, Editor. Sexological Aspects of Substance Use and Abuse. Proceedings, Volume 14(1-2), 1982. 18. Smith DE & Wesson DR, Editors. The Benzodiazepines: Two Decades of Research and Clinical Experience.

Proceedings, Volume 15(1-2), January-June, 1983. 19. Smith DE & Wesson DR, Editors, Treating the Cocaine Abuser. Hazelden Foundation, 1985. 20. Smith DE & Wesson DR, Editors. MDMA: Ecstasy as an Adjunct to Psychotherapy and a Street Drug of Abuse.

California Society for the Treatment of Alcoholism and Drug Dependence News, September, 1985. 21. Smith DE & Wesson DR, Editors. The Benzodiazepines: Current Standards for Medical Practice. MTP Press, London. 22. Smith DE, Buxton ME & Zweben, JE, Editors. Professional Treatment and the 12 Step Process. Journal of Psychoactive

Drugs, Volume 19(3), 1987. 23. Seymour RB, Wesson DR & Smith DE, Editors. MDMA: Proceedings of the Conference. Journal of Psychoactive

Drugs, Volume 18(4), 1986. 24. Landry MJ, Smith DE & Newmeyer JA, Editors. AIDS and Chemical Dependency: Social and Clinical Issues. Journal

of Psychoactive Drugs, Volume 20(2), 1988. 25. Smith DE, Editor. Therapeutic Drugs and Drugs of Abuse in the Era of the Drug Free Workplace. Journal of

Psychoactive Drugs, Volume 22(4), 1990. 26. Smith DE, Editor. Prescription Drug Issues: Public Policy and Clinical Practice. Journal of Psychoactive Drugs,

Volume 23(4), 1991. 27. Dupont, RL, Smith, DE, Deutsch, R, Clark, HW, Editors. Drugs, Crime & Violence. Journal of Psychoactive Drugs,

Volume 29(4), 1997. 28. Smith DE & Heilig, S, Editors. Marijuana at The Millenium: Medical and Social Implications. Journal of Psychoactive

Drugs, Volume 30(2), 1998.

XVI. Monographs

1. Smith DE, Contributing Author. Medical Care at Large Youth Gatherings. National Clearinghouse on Drug

Information, 1976. 2. Smith DE, Co-Author. Medical Treatment for Complications of Polydrug Abuse. Treatment Manual I, National Institute

on Drug Abuse, 1976. 3. Smith DE, Co-Author. The Diagnosis and Treatment of the PCP Abuse Syndrome. PCP Phencyclidine Abuse: An

Appraisal, Petersen & Stillman, August, 1978.


4. Smith DE, Co-Author. Cocaine: A Second Look. American Council on Marijuana and Other Psychoactive Drugs, Rockville, Maryland, 1983.

5. Smith DE & Wesson DR. Cocaine: Treatment Perspectives. Cocaine Use in America: Epidemiological and Clinical

Perspectives, Institute on Drug Abuse Research Monograph Series 61, 1985. 6. Smith DE, Wesson DR, Steffens S & Jue K. L-Tryptophan Treatment of Cocaine Dependency and the Eosinophilia

Myalgia Syndrome. Problems of Drug Dependence, NIDA Research Monograph #132, Rockville, Maryland, 1992.

XVIII. Published Abstracts:

1. Schermann, JM, Sandouk, P, Redureau, M, Galons, H, Hiance, M, Kaplan, SA, Smith, DE. Inhibition of cocaine brain uptake and facilitation of cocaine efflux from the brain by a systemic specific antibody. Published abstract. College on Problems of Drug Dependence (CPDD), 61st Annual Scientific Meeting, June 12 – 17, 1999, Acapulco, Mexico.

2. Kaplan, SA, Smith, DE, Markland, P, Perkins, BH, Ferrell, TM, Fulton, R, Nettles, HS, Staas, JK, Tice, TR. In vivo

confirmation of naltrexone sustained release by microencapsulation in poly(D,L-lactide) for prolonged drug addiction therapy. Published abstract. College on Problems of Drug Dependence (CPDD), 61st Annual Scientific Meeting, June 12 – 17, 1999, Acapulco, Mexico.

XVII. Books

1. Smith DE, Co-Editor. Drug Abuse Papers 1969. University of California, Berkeley, 1969. 2. Smith DE, Editor. The New Social Drug: Cultural, Medical and Legal Perspectives on Marijuana. Prentice-Hall, Inc,

1970. 3. Smith DE, Co-Author. Love Needs Care: A History of San Francisco’s Haight Ashbury Free Medical Clinic. Little Brown

& Co., 1971. 4. Smith DE, Co-Editor. The Free Clinic: Community Approaches to Health Care and Drug Abuse. STASH Press, 1972. 5. Smith DE, Co-Editor. It’s So Good, Don’t Even Try It Once: Heroin in Perspective. Prentice-Hall, Inc., 1972. 6. Smith DE, Co-Author. Drugs in the Classroom. The C.V. Mosby Co., 1973. 7. Smith DE, Co-Editor. Uppers and Downers. Prentice-Hall, Inc., 1973. 8. Smith DE, Co-Author. Barbiturates: Their Use, Misuse and Abuse. Behavioral Publications, Inc., 1976. 9. Smith DE, Co-Editor. A Multicultural View of Drug Abuse: Proceedings of the National Drug Abuse Conference 1977.

Schenkman and G.K. Hall Publishers, Cambridge, Massachusetts, 1978. 10. Smith DE, Co-Editor. Amphetamine Use, Misuse and Abuse: Proceedings of the National Amphetamine Conference 1978.

G.K. Hall Publishers, Boston, 1979. 11. Smith DE, Wesson DR & Eiswirth NA. Cocaine in America. Hazelden Foundation, Minneapolis, 1981. 12. Smith DE, Co-Editor. PCP: Problems and Prevention. Kendall Hunt, Dubuque, Iowa, 1982. 13. Smith DE, Medical Consultant. The Little Black Pill Book. Bantam Books, New York, 1983.


14. Smith DE, Medical Consultant. The Coke Book. Berkeley Books, New York, 1984. 15. Smith DE, Gold MS, Olden K & Dwyer BJ. Cocaine: Helping Patients Avoid the End of the Line. 1985. 16. Smith DE & Wesson DR. Treating the Cocaine Abuser. Hazelden Foundation, 1985. 17. Smith DE, Co-Editor. The Benzodiazepines: Current Standards for Medical Practice. MTP Press, Ltd., Boston, 1985. 18. Seymour RB & Smith DE. The Physician’s Guide to Psychoactive Drugs. The Haworth Press, New York, 1987. 19. Seymour RB & Smith DE. Guide to Psychoactive Drugs: An Up to the Minute Reference to Mind Altering Substances.

Harrington Park Press, New York, 1987. 20. Seymour RB & Smith DE. Drugfree: A Unique, Positive Approach to Staying off Alcohol and Other Drugs. Facts on File

Publications, New York, 1987. 21. Seymour RB & Smith DE. Still Free After All These Years: Two Decades With The Haight Ashbury Free Medical Clinic.

Westwind Associates, Sausalito, 1987. 22. Smith DE & Wesson DR. Treating Cocaine Dependency. Hazelden Foundation, Minneapolis, 1988. 23. Wesson DR & Smith DE. Treating Opiate Dependency. Hazelden Foundation, Minneapolis, 1989. 24. Seymour RB, Smith DE, Inaba DE & Landry MJ. The New Drugs: Look Alike Drugs, Drugs of Deception and Designer

Drugs. Hazelden Foundation, Center City, 1989. 25. Wesson DR, Smith DE, Steffens SC, Co-Editors. Crack and Ice: Treating Smokable Stimulant Abuse. Hazelden

Foundation, Center City, 1992. 26. Smith, DE & Seymour, RB. Clinician’s Guide to Substance Abuse. McGraw-Hill Medical Publishing Division, 2001.

XVIII. Drug Abuse Films, Consultant

1. LSD-25, 1967. 2. Guidance Associate Film Series, 1968. 3. You Can’t Grow a Green Plant in a Closet, 1968. 4. The Speed Scene, 1969. 5. Darkness, Darkness, 1970. 6. Glass House, 1971. 7. Junkies Are People, 1973. 8. Film on the National Commission on Marijuana and Drug Abuse Report, 1973. 9. Escape to Nowhere, 1978. 10. Uppers, Downers, All Arounders, Cinemed Inc., 1984; 2001 CNS Productions, Inc. 11. Through the Looking Glass, Hazelden, 1984. 12. The Haight Ashbury Cocaine Film, Cinemed, Inc., 1985. 13. Haight Ashbury Video Series, Cinemed, Inc., 1988. 14. Haight Ashbury Heroin Film, 1999.

# # #